Showing 1 to 3 of 3 results


SOX6 Protein Identified as Potential Therapeutic Target for Multiple Sclerosis
US scientists have discovered that a protein called SOX6 acts as a brake on myelin development and may be responsible for the inability of oligodendrocytes to repair damaged myelin sheaths in multiple sclerosis, offering a potential new treatment avenue.
SOX6 Protein Identified as Potential Therapeutic Target for Multiple Sclerosis
US scientists have discovered that a protein called SOX6 acts as a brake on myelin development and may be responsible for the inability of oligodendrocytes to repair damaged myelin sheaths in multiple sclerosis, offering a potential new treatment avenue.
Progress
40% Bias Score


Marathon Running Temporarily Reduces Brain Myelin, Study Finds
A study of ten marathon runners revealed a temporary reduction in brain myelin levels after a 42km run, which fully replenished within two months; researchers suggest the brain utilizes myelin as fuel when carbohydrate reserves are depleted, potentially offering insights into treating myelin-related...
Marathon Running Temporarily Reduces Brain Myelin, Study Finds
A study of ten marathon runners revealed a temporary reduction in brain myelin levels after a 42km run, which fully replenished within two months; researchers suggest the brain utilizes myelin as fuel when carbohydrate reserves are depleted, potentially offering insights into treating myelin-related...
Progress
36% Bias Score

Williams Syndrome: Extreme Friendliness and its Genetic Roots
Williams syndrome (WS), affecting 1 in 7,500, causes excessive friendliness towards strangers due to a deletion of 25-27 genes on chromosome 7, impacting brain development and potentially oxytocin levels; research explores GTF2I's role and potential clemastine treatment.

Williams Syndrome: Extreme Friendliness and its Genetic Roots
Williams syndrome (WS), affecting 1 in 7,500, causes excessive friendliness towards strangers due to a deletion of 25-27 genes on chromosome 7, impacting brain development and potentially oxytocin levels; research explores GTF2I's role and potential clemastine treatment.
Progress
32% Bias Score
Showing 1 to 3 of 3 results